CCND1 and breast cancer: In the present study, the inhibition of de novo protein synthesis by CHX notably shortened the half-life of Cyclin D1 in the 2 SHP2 knockout breast cancer cell lines, thus indicating that SHP2 loss resulted in rapid degradation of Cyclin D1.